Skip to main content
Erschienen in: Nuclear Medicine and Molecular Imaging 4/2017

25.07.2017 | Case Report

Altered Biodistribution of 99mTc-DPD on Bone Scan After Intravenous Iron Supplement

verfasst von: Eonwoo Shin, Minyoung Oh, Changhwan Sung, Ki-Hun Kim, Jin-Sook Ryu

Erschienen in: Nuclear Medicine and Molecular Imaging | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

We report a case with altered biodistribution of 99mTc-dicarboxypropane diphosphonate (99mTc-DPD) on whole body bone scan after intravenous iron supplement therapy. A 47-year-old male patient who had recently been detected with a hepatic mass suggestive of hepatocellular carcinoma underwent bone scan as staging work-up before surgery. Bone scan images at 3 h after injection of 99mTc-DPD demonstrated unusually increased blood pool activities in the heart, liver, and spleen with usual skeletal uptakes. The patient had been treated for severe anemia from hemorrhoid with two intravenous administration of ferric hydroxide carboxymaltose complex at approximately 22 h and 2 h prior to the 99mTc-DPD injection, which we consider as the most probable cause of altered biodistribution of 99mTc-DPD.
Literatur
1.
Zurück zum Zitat Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942–53.CrossRefPubMed Hamaoka T, Madewell JE, Podoloff DA, Hortobagyi GN, Ueno NT. Bone imaging in metastatic breast cancer. J Clin Oncol. 2004;22:2942–53.CrossRefPubMed
2.
Zurück zum Zitat Bergqvist L, Brismar J, Cederquist E, Darte L, Naversten Y, Palmer J. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP. Acta Radiol Diagn (Stockh). 1984;25:217–23.CrossRef Bergqvist L, Brismar J, Cederquist E, Darte L, Naversten Y, Palmer J. Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP. Acta Radiol Diagn (Stockh). 1984;25:217–23.CrossRef
3.
Zurück zum Zitat Vorne M, Vahatalo S, Lantto T. A clinical comparison of 99mTc-DPD and two 99mTc-MDP agents. Eur J Nucl Med. 1983;8:395–7.CrossRefPubMed Vorne M, Vahatalo S, Lantto T. A clinical comparison of 99mTc-DPD and two 99mTc-MDP agents. Eur J Nucl Med. 1983;8:395–7.CrossRefPubMed
4.
Zurück zum Zitat Hesslewood S, Leung E. Drug interactions with radiopharmaceuticals. Eur J Nucl Med. 1994;21:348–56.CrossRefPubMed Hesslewood S, Leung E. Drug interactions with radiopharmaceuticals. Eur J Nucl Med. 1994;21:348–56.CrossRefPubMed
5.
Zurück zum Zitat Vallabhajosula S, Killeen RP, Osborne JR. Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. Semin Nucl Med. 2010;40:220–41.CrossRefPubMed Vallabhajosula S, Killeen RP, Osborne JR. Altered biodistribution of radiopharmaceuticals: role of radiochemical/pharmaceutical purity, physiological, and pharmacologic factors. Semin Nucl Med. 2010;40:220–41.CrossRefPubMed
6.
Zurück zum Zitat Zimmer AM, Pavel DG. Experimental investigations of the possible cause of liver appearance during bone scanning. Radiology. 1978;126:813–6.CrossRefPubMed Zimmer AM, Pavel DG. Experimental investigations of the possible cause of liver appearance during bone scanning. Radiology. 1978;126:813–6.CrossRefPubMed
7.
Zurück zum Zitat Alazraki N, Scott S, Manaster B, Wooten W, Murphy K. Effect of glucocorticoids on sensitivity of Tc-99m phosphonate bone imaging for detecting bone trauma. J Nucl Med. 1987;28:606. Alazraki N, Scott S, Manaster B, Wooten W, Murphy K. Effect of glucocorticoids on sensitivity of Tc-99m phosphonate bone imaging for detecting bone trauma. J Nucl Med. 1987;28:606.
8.
Zurück zum Zitat Lutrin CL, McDougall IR, Goris ML. Intense concentration of technetium-99m pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease. Radiology. 1978;128:165–7.CrossRefPubMed Lutrin CL, McDougall IR, Goris ML. Intense concentration of technetium-99m pyrophosphate in the kidneys of children treated with chemotherapeutic drugs for malignant disease. Radiology. 1978;128:165–7.CrossRefPubMed
9.
Zurück zum Zitat Sandler ED, Parisi MT, Hattner RS. Duration of etidronate effect demonstrated by serial bone scintigraphy. J Nucl Med. 1991;32:1782–4.PubMed Sandler ED, Parisi MT, Hattner RS. Duration of etidronate effect demonstrated by serial bone scintigraphy. J Nucl Med. 1991;32:1782–4.PubMed
10.
Zurück zum Zitat Loutfi I, Collier BD, Mohammed AM. Nonosseous abnormalities on bone scans. J Nucl Med Technol. 2003;31:149–53. quiz 54-6PubMed Loutfi I, Collier BD, Mohammed AM. Nonosseous abnormalities on bone scans. J Nucl Med Technol. 2003;31:149–53. quiz 54-6PubMed
11.
Zurück zum Zitat VanAntwerp J, Hall J, OMara R, Hilts S. Bone scan abnormality produced by interaction of Tc-99m diphosphonate with iron dextran (Imferon) [abstract]. J Nucl Med. 1975;16:577. VanAntwerp J, Hall J, OMara R, Hilts S. Bone scan abnormality produced by interaction of Tc-99m diphosphonate with iron dextran (Imferon) [abstract]. J Nucl Med. 1975;16:577.
12.
Zurück zum Zitat MacDonald J. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report. J Nucl Med Technol. 2001;29:32–6.PubMed MacDonald J. Idiopathic hepatic uptake of (99m)Tc methylene diphosphonate: a case report. J Nucl Med Technol. 2001;29:32–6.PubMed
13.
Zurück zum Zitat Byun HH, Rodman SG, Chung KE. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J Nucl Med. 1976;17:374–5.PubMed Byun HH, Rodman SG, Chung KE. Soft-tissue concentration of 99mTc-phosphates associated with injections of iron dextran complex. J Nucl Med. 1976;17:374–5.PubMed
14.
Zurück zum Zitat Parker JA, Jones AG, Davis MA, Mcilmoyle G, Tow DE. Reduced uptake of bone-seeking radiopharmaceuticals related to iron excess. Clin Nucl Med. 1976;1:267–8.CrossRef Parker JA, Jones AG, Davis MA, Mcilmoyle G, Tow DE. Reduced uptake of bone-seeking radiopharmaceuticals related to iron excess. Clin Nucl Med. 1976;1:267–8.CrossRef
15.
Zurück zum Zitat Choy D, Murray IP, Hoschl R. The effect of iron on the biodistribution of bone scanning agents in humans. Radiology. 1981;140:197–202.CrossRefPubMed Choy D, Murray IP, Hoschl R. The effect of iron on the biodistribution of bone scanning agents in humans. Radiology. 1981;140:197–202.CrossRefPubMed
16.
Zurück zum Zitat Forauer AR, Grossman SJ, Joyce JM. Altered biodistribution of Tc-99m HMDP on bone scintigraphy from recent intravenous iron therapy. Clin Nucl Med. 1994;19:817–8.CrossRefPubMed Forauer AR, Grossman SJ, Joyce JM. Altered biodistribution of Tc-99m HMDP on bone scintigraphy from recent intravenous iron therapy. Clin Nucl Med. 1994;19:817–8.CrossRefPubMed
17.
Zurück zum Zitat Jones AG, Francis MD, Davis MA. Bone scanning: radionuclidic reaction mechanisms. Semin Nucl Med. 1976;6:3–18.CrossRefPubMed Jones AG, Francis MD, Davis MA. Bone scanning: radionuclidic reaction mechanisms. Semin Nucl Med. 1976;6:3–18.CrossRefPubMed
18.
Zurück zum Zitat McRae J, Hambright P, Valk P, Bearden AJ. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of ca and Fe (ii) on in vivo distribution. J Nucl Med. 1976;17:208–11.PubMed McRae J, Hambright P, Valk P, Bearden AJ. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of ca and Fe (ii) on in vivo distribution. J Nucl Med. 1976;17:208–11.PubMed
19.
Zurück zum Zitat Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Eur J Nucl Med. 1983;8:118–22.CrossRefPubMed Pauwels EK, Blom J, Camps JA, Hermans J, Rijke AM. A comparison between the diagnostic efficacy of 99mTc-MDP, 99mTc-DPD and 99mTc-HDP for the detection of bone metastases. Eur J Nucl Med. 1983;8:118–22.CrossRefPubMed
Metadaten
Titel
Altered Biodistribution of 99mTc-DPD on Bone Scan After Intravenous Iron Supplement
verfasst von
Eonwoo Shin
Minyoung Oh
Changhwan Sung
Ki-Hun Kim
Jin-Sook Ryu
Publikationsdatum
25.07.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Nuclear Medicine and Molecular Imaging / Ausgabe 4/2017
Print ISSN: 1869-3474
Elektronische ISSN: 1869-3482
DOI
https://doi.org/10.1007/s13139-017-0486-5

Weitere Artikel der Ausgabe 4/2017

Nuclear Medicine and Molecular Imaging 4/2017 Zur Ausgabe